Xueqin F. Chen

261 Huansha Road
Hangzhou, 310006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications

Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS.

Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS.

Journal: Science translational medicine
Published: August 12, 2026

Liver-originated selective autophagy of BTD by alectinib underlies concurrent hepatotoxicity and dermatotoxicity.

Liver-originated selective autophagy of BTD by alectinib underlies concurrent hepatotoxicity and dermatotoxicity.

Journal: Autophagy
Published: May 10, 2026

Entrectinib binds to HMGB1 and activates cardiomyocyte autophagy by inhibiting OTUD5-MTORC1 signaling to induce cardiotoxicity.

Entrectinib binds to HMGB1 and activates cardiomyocyte autophagy by inhibiting OTUD5-MTORC1 signaling to induce cardiotoxicity.

Journal: Autophagy
Published: October 20, 2025

Optimized patient-derived lung cancer organoids recapitulating the immune landscape for precision therapy evaluation.

Optimized patient-derived lung cancer organoids recapitulating the immune landscape for precision therapy evaluation.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 16, 2025

Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer.

Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer.

Journal: Cancer letters
Published: September 07, 2025

Development of a machine learning-based model to predict prognosis of resected invasive pulmonary adenocarcinoma.

Development of a machine learning-based model to predict prognosis of resected invasive pulmonary adenocarcinoma.

Journal: Journal of thoracic disease
Published: August 14, 2025

Case Report: A rare hyperplastic polyp with synchronous high-grade intraepithelial neoplasia in both glandular and squamous epithelium in autoimmune gastritis.

Case Report: A rare hyperplastic polyp with synchronous high-grade intraepithelial neoplasia in both glandular and squamous epithelium in autoimmune gastritis.

Journal: Frontiers in oncology
Published: June 04, 2025

Off-target engagement of sotorasib with PPARγ via FABP4: a novel mechanism driving interstitial lung disease.

Off-target engagement of sotorasib with PPARγ via FABP4: a novel mechanism driving interstitial lung disease.

Journal: Cell communication and signaling : CCS
Published: May 09, 2025

Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials.

Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials.

Journal: Cancer communications (London, England)
Published: March 24, 2025

Tumor Cavitation with Anlotinib Treatment in Lung Adenocarcinoma.

Tumor Cavitation with Anlotinib Treatment in Lung Adenocarcinoma.

Journal: Diagnostics (Basel, Switzerland)
Published: March 08, 2025

Combination of anlotinib and irinotecan as second-line therapy in extensive-stage small-cell lung cancer relapsed within six months: a single-arm phase Ⅱ study.

Combination of anlotinib and irinotecan as second-line therapy in extensive-stage small-cell lung cancer relapsed within six months: a single-arm phase Ⅱ study.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 12, 2025

Corrigendum to "SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer" [Cancer Lett. 524 (2022) 268-283].

Corrigendum to "SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer" [Cancer Lett. 524 (2022) 268-283].

Journal: Cancer letters
Published: November 24, 2024
Showing 1-12 of 77

Last Updated: 09/26/2026